Clinical Trials in Denver

Showing 6101-6120 of 18,161 trials

Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response

NCT02480283

This study plans to evaluate the effects of chronic cannabis smoking on lung health by evaluating its effects on pulmonary health, lung physiology and alveolar macrophage function.

Cannabis SmokingOxidative Stress

University of Colorado, Denver100 participantsStarted Nov 2015

Aurora, Colorado, United States

RECRUITING8.4 miles

The Pediatric Spine Foundation

NCT02540915

The Pediatric Spine Foundation is a registry designed to assist spine surgeons to efficiently identify and track patients with chest wall and spinal disorders.

Chest Wall and Spinal Disorders

University of Colorado, Denver5,000 participantsStarted Nov 2013

Aurora, Colorado, United States

COMPLETEDPhase 1285 miles

A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors

NCT04861987

This study is an open label, multicenter study in patients who have advanced, relapsed refractory GI cancer or are not relapsed/refractory but are intolerant to other therapies who, in the judgment of investigators, are candidates for fluoropyrimidine monotherapy.

Advanced CancerRefractory CancerTumor Gastric

Processa Pharmaceuticals23 participantsStarted Jun 2021

Omaha, Nebraska, United States • New Brunswick, New Jersey, United States • Santa Fe, New Mexico, United States +3 more locations

Chronic Cannabis Smoking, Oxidative Stress and the Pulmonary Innate Immune Response

The Pediatric Spine Foundation

A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors

Find Trials by Condition in Denver

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG)

Study of LAU-7b in the Treatment of Cystic Fibrosis in Adults

Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) for Advanced Melanoma in Anti-Programmed Death-1/Programmed Death-Ligand 1 (PD-1/L1)-Exposed Participants (MK-7902-004/E7080-G000-225/LEAP-004)

Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy

Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors

First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)

Atrasentan in Patients With IgA Nephropathy

Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial - Follow Up Long Term Extension (IMPAHCT-FUL)

The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study

Effect of Isotretinoin on Immune Activation Among HIV-1 Infected Subjects With Incomplete CD4+ T Cell Recovery

Study of IMC-I109V in Non-cirrhotic HBeAg-negative Chronic HBV Infection

A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors

A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Lay-Delivered Behavioral Activation in Senior Centers

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab or Rituximab Biosimilar (Truxima) (R-CHP) in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-007)